Yamato: EAST BUY (01797) impressive performance for the first half of the year, reaffirms outperforming the market rating.
In light of the performance released by the Yamato Group, opinions on it have become more positive, believing that it has successfully overcome operational difficulties.
Daiwa released a research report stating that based on the better-than-expected performance of product trading volume and gross profit margin of EAST BUY (01797), the group's profit forecast for the next two years has been raised by 42% to 97%. Considering the recovery in product trading volume, the "outperform the market" rating is reiterated, and the new 12-month target price is raised from HK$13.5 to HK$29, based on a 32 times price-earnings ratio for the average earnings per share of the next two years (originally 23 times).
EAST BUY announced its performance for the first half of the 2026 fiscal year, with adjusted net profit of RMB 257 million, reversing the loss from last year; and the strong performance of a 36% gross profit margin was the key good news, with the gross profit margin of its own brand expanding from 24% to 29%, mainly benefiting from scale effects and the contribution of high-profit products such as health, nutrition, and daily consumer goods.
Daiwa stated that after the group announced its performance, its view has become more positive, believing that it has overcome operating difficulties, with good development of its own brand, structural reduction of operating costs, and the opening of non-Douyin channels providing important choices for performance growth, and believing that the risk-return profile of the stock has improved.
Related Articles

HK Stock Market Move | Suzhou Novosense Microelectronics (02676) rises more than 8%, the company expects last year's losses to narrow, and the supply-demand relationship in the analog chip industry is expected to change.

HK Stock Market Move | AK MEDICAL (01789) rose more than 4% plans to repurchase up to HK$150 million worth of shares. It has won multiple joint bids in the 26-year history of Siasun Robot & Automation, pending public announcement.

HK Stock Market Move | ASMPT (00522) rose more than 5% in early trading, the divestment of SMT business will help the company focus on its semiconductor business.
HK Stock Market Move | Suzhou Novosense Microelectronics (02676) rises more than 8%, the company expects last year's losses to narrow, and the supply-demand relationship in the analog chip industry is expected to change.

HK Stock Market Move | AK MEDICAL (01789) rose more than 4% plans to repurchase up to HK$150 million worth of shares. It has won multiple joint bids in the 26-year history of Siasun Robot & Automation, pending public announcement.

HK Stock Market Move | ASMPT (00522) rose more than 5% in early trading, the divestment of SMT business will help the company focus on its semiconductor business.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


